• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N-甲基-D-天冬氨酸受体NR2B调节域的同源性建模及艾芬地尔结合分析

Homology modeling of NR2B modulatory domain of NMDA receptor and analysis of ifenprodil binding.

作者信息

Marinelli Luciana, Cosconati Sandro, Steinbrecher Thomas, Limongelli Vittorio, Bertamino Alessia, Novellino Ettore, Case David A

机构信息

Dipartimento di Chimica Farmaceutica e Tossicologica, Università di Napoli Federico II, Via D. Montesano 49, 80131 Napoli, Italy.

出版信息

ChemMedChem. 2007 Oct;2(10):1498-510. doi: 10.1002/cmdc.200700091.

DOI:10.1002/cmdc.200700091
PMID:17849398
Abstract

NMDA receptors are glutamate-gated ion channels (iGluRs) that are involved in several important physiological functions such as neuronal development, synaptic plasticity, learning, and memory. Among iGluRs, NMDA receptors have been perhaps the most actively investigated for their role in chronic neurodegeneration such as Alzheimer's, Parkinson's, and Huntington's diseases. Recent studies have shown that the NTD of subunit NR2B modulates ion channel gating through the binding of allosteric modulators such as the prototypical compound ifenprodil. In the present paper, the construction of a three-dimensional model for the NR2B modulatory domain is described and docking calculations allow, for the first time, definition of the ifenprodil binding pose at an atomic level and fully explain all the available structure-activity relationships. Moreover, in an attempt to add further insight into the ifenprodil mechanism of action, as it is not completely clear if it binds and stabilizes an open or a closed conformation of the NR2B modulatory domain, a matter, which is fundamental for the rational design of NMDA antagonists, MD simulations followed by an MM-PBSA analysis were performed. These calculations reveal that the closed conformation of the R1-R2 domain, rather than the open, constitutes the high affinity binding site for ifenprodil and that a profound stabilization of the closed conformation upon ifenprodil binding occurs. Thus, for a rational design and/or for virtual screening experiments, the closed conformation of the R1-R2 domain should be taken into account and our 3D model can provide valuable hints for the design of NR2B-selective antagonists.

摘要

NMDA受体是谷氨酸门控离子通道(离子型谷氨酸受体),参与多种重要的生理功能,如神经元发育、突触可塑性、学习和记忆。在离子型谷氨酸受体中,NMDA受体因其在慢性神经退行性疾病(如阿尔茨海默病、帕金森病和亨廷顿病)中的作用,可能是研究最为活跃的。最近的研究表明,亚基NR2B的N端结构域通过与变构调节剂(如典型化合物ifenprodil)结合来调节离子通道门控。在本文中,描述了NR2B调节结构域三维模型的构建,对接计算首次在原子水平上确定了ifenprodil的结合姿势,并充分解释了所有现有的构效关系。此外,为了进一步深入了解ifenprodil的作用机制,由于尚不完全清楚它是结合并稳定NR2B调节结构域的开放构象还是关闭构象,而这一问题对于合理设计NMDA拮抗剂至关重要,因此进行了分子动力学模拟并随后进行MM-PBSA分析。这些计算表明,R1-R2结构域的关闭构象而非开放构象构成了ifenprodil的高亲和力结合位点,并且ifenprodil结合后关闭构象会发生显著稳定。因此,对于合理设计和/或虚拟筛选实验,应考虑R1-R2结构域的关闭构象,我们的三维模型可为设计NR2B选择性拮抗剂提供有价值的线索。

相似文献

1
Homology modeling of NR2B modulatory domain of NMDA receptor and analysis of ifenprodil binding.N-甲基-D-天冬氨酸受体NR2B调节域的同源性建模及艾芬地尔结合分析
ChemMedChem. 2007 Oct;2(10):1498-510. doi: 10.1002/cmdc.200700091.
2
Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors.N-甲基-D-天冬氨酸受体对NR2B选择性拮抗剂识别的结构基础。
Mol Pharmacol. 2009 Jan;75(1):60-74. doi: 10.1124/mol.108.050971. Epub 2008 Oct 15.
3
Identification of critical residues in the amino terminal domain of the human NR2B subunit involved in the RO 25-6981 binding pocket.鉴定人NR2B亚基氨基末端结构域中参与RO 25-6981结合口袋的关键残基。
J Pharmacol Exp Ther. 2003 Dec;307(3):897-905. doi: 10.1124/jpet.103.056291. Epub 2003 Oct 8.
4
Use of trifluoroperazine isolates a [(3)H]Ifenprodil binding site in rat brain membranes with the pharmacology of the voltage-independent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits.三氟拉嗪的使用在大鼠脑膜中分离出一个[(3)H]艾芬地尔结合位点,其药理学特性与含NR2B亚基的N-甲基-D-天冬氨酸受体上的电压非依赖性艾芬地尔位点相同。
J Pharmacol Exp Ther. 2001 Jan;296(1):150-9.
5
The function of the amino terminal domain in NMDA receptor modulation.N-甲基-D-天冬氨酸受体调节中氨基末端结构域的功能。
J Mol Graph Model. 2005 Jan;23(4):381-8. doi: 10.1016/j.jmgm.2004.11.006.
6
Developmental regulation of NMDA receptor 2B subunit mRNA and ifenprodil binding in the zebra finch anterior forebrain.斑胸草雀前脑NMDA受体2B亚基mRNA及艾芬地尔结合的发育调控
J Neurobiol. 1999 May;39(2):155-67.
7
Development of a three-dimensional model for the N-methyl-D-aspartate NR2A subunit.
J Med Chem. 2005 Aug 25;48(17):5489-94. doi: 10.1021/jm050174x.
8
An aspartate residue in the extracellular loop of the N-methyl-D-aspartate receptor controls sensitivity to spermine and protons.N-甲基-D-天冬氨酸受体细胞外环中的一个天冬氨酸残基控制着对精胺和质子的敏感性。
Mol Pharmacol. 1996 Jun;49(6):1131-41.
9
Glutamate-based therapeutic approaches: NR2B receptor antagonists.基于谷氨酸的治疗方法:NR2B受体拮抗剂。
Curr Opin Pharmacol. 2006 Feb;6(1):68-74. doi: 10.1016/j.coph.2005.11.001. Epub 2005 Dec 22.
10
Molecular determinants of ligand discrimination in the glutamate-binding pocket of the NMDA receptor.N-甲基-D-天冬氨酸受体谷氨酸结合口袋中配体识别的分子决定因素。
Neuropharmacology. 2004 Dec;47(7):994-1007. doi: 10.1016/j.neuropharm.2004.07.041.

引用本文的文献

1
A genetically encoded secreted toxin potentiates synaptic NMDA receptors in hippocampal neurons and confers neuroprotection.一种基因编码的分泌毒素增强海马神经元中的突触N-甲基-D-天冬氨酸受体并赋予神经保护作用。
PNAS Nexus. 2025 Feb 6;4(2):pgaf041. doi: 10.1093/pnasnexus/pgaf041. eCollection 2025 Feb.
2
Nafamostat and sepimostat identified as novel neuroprotective agents via NR2B N-methyl-D-aspartate receptor antagonism using a rat retinal excitotoxicity model.纳法莫司他和西普莫司他通过大鼠视网膜兴奋性毒性模型中的 NR2B N-甲基-D-天冬氨酸受体拮抗作用被鉴定为新型神经保护剂。
Sci Rep. 2019 Dec 31;9(1):20409. doi: 10.1038/s41598-019-56905-x.
3
In Silico Studies in Drug Research Against Neurodegenerative Diseases.
计算机药物研究在神经退行性疾病防治中的应用
Curr Neuropharmacol. 2018;16(6):664-725. doi: 10.2174/1570159X15666170823095628.
4
Alcohol and NMDA receptor: current research and future direction.酒精与 NMDA 受体:当前研究与未来方向。
Front Mol Neurosci. 2013 May 28;6:14. doi: 10.3389/fnmol.2013.00014. eCollection 2013.
5
Allosteric modulators for the treatment of schizophrenia: targeting glutamatergic networks.治疗精神分裂症的变构调节剂:靶向谷氨酸能网络。
Curr Top Med Chem. 2013;13(1):26-54. doi: 10.2174/1568026611313010005.
6
Mapping the binding of GluN2B-selective N-methyl-D-aspartate receptor negative allosteric modulators.描绘 GluN2B 选择性 N-甲基-D-天冬氨酸受体负变构调节剂的结合情况。
Mol Pharmacol. 2012 Aug;82(2):344-59. doi: 10.1124/mol.112.078568. Epub 2012 May 17.
7
Control of assembly and function of glutamate receptors by the amino-terminal domain.通过氨基末端结构域控制谷氨酸受体的组装和功能。
Mol Pharmacol. 2010 Oct;78(4):535-49. doi: 10.1124/mol.110.067157. Epub 2010 Jul 21.
8
Structure of the zinc-bound amino-terminal domain of the NMDA receptor NR2B subunit.NMDA 受体 NR2B 亚基锌结合氨基末端结构域。
EMBO J. 2009 Dec 16;28(24):3910-20. doi: 10.1038/emboj.2009.338.
9
Control of NMDA receptor function by the NR2 subunit amino-terminal domain.NR2亚基氨基末端结构域对NMDA受体功能的调控
J Neurosci. 2009 Sep 30;29(39):12045-58. doi: 10.1523/JNEUROSCI.1365-09.2009.
10
Synthesis, structural activity-relationships, and biological evaluation of novel amide-based allosteric binding site antagonists in NR1A/NR2B N-methyl-D-aspartate receptors.新型酰胺基变构结合位点拮抗剂在NR1A/NR2B N-甲基-D-天冬氨酸受体中的合成、构效关系及生物学评价
Bioorg Med Chem. 2009 Sep 1;17(17):6463-80. doi: 10.1016/j.bmc.2009.05.085. Epub 2009 Jul 5.